Maccecchini Maria-Luisa 4
4 · Annovis Bio, Inc. · Filed Feb 8, 2023
Insider Transaction Report
Form 4
Maccecchini Maria-Luisa
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2023-02-06−52,755→ 0 totalExercise: $0.14Exp: 2027-04-01→ Common Stock (52,755 underlying) - Exercise/Conversion
Common Stock
2023-02-06$0.14/sh+52,755$7,386→ 1,040,489 total
Footnotes (1)
- [F1]All of the shares underlying the option are fully vested and exercisable.